Developer of remote control technology for the cardiac
catheterization laboratory.
Employees: 15
Main Markets:
Catheterization Laboratories.
Overview
CORINDUS LTD., was established in 2002 as NaviCath, within the
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
framework of the Technion Entrepreneurial Incubator Company
(TEIC) in Haifa, Israel.
CORINDUS holds a patent for "Remote Control Catheterization"
technology. Its CorPath catheter manipulation system allows
physicians to advance and torque coronary guide wires and stent
systems in a patient's artery from a remote location. The system
is noninvasive and accommodates all state-of-the-art
interventional cath lab devices.
With the increasing volume and complexity of interventional
procedures, the health hazards associated with the exposure of
physicians and staff to radiation has become a significant
concern. As remote control catheterization becomes standard
practice, the risks of radiation can be significantly reduced.
Additionally, fatigue and back pain, a major problem for
operators caused by the need to wear lead radiation protection
garments, can be virtually eliminated.
Initial clinical trials with CorPath successfully demonstrated
its safety and efficacy. Further clinical study to obtain FDA
marketing approval is underway.
